Kenvue Inc. (NYSE:KVUE) Shares Purchased by Vanguard Group Inc.

Vanguard Group Inc. lifted its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 0.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 218,543,705 shares of the company's stock after buying an additional 1,636,741 shares during the period. Vanguard Group Inc. owned approximately 11.40% of Kenvue worth $4,665,908,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. LPL Financial LLC grew its holdings in shares of Kenvue by 4.9% during the fourth quarter. LPL Financial LLC now owns 2,064,405 shares of the company's stock worth $44,075,000 after purchasing an additional 96,030 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new position in Kenvue during the 4th quarter worth approximately $14,779,000. Sei Investments Co. increased its position in Kenvue by 1.0% during the fourth quarter. Sei Investments Co. now owns 2,207,060 shares of the company's stock worth $47,121,000 after buying an additional 20,802 shares during the period. Mizuho Securities USA LLC lifted its stake in Kenvue by 46.3% in the fourth quarter. Mizuho Securities USA LLC now owns 181,712 shares of the company's stock valued at $3,880,000 after buying an additional 57,524 shares during the last quarter. Finally, Virtu Financial LLC acquired a new stake in shares of Kenvue in the fourth quarter valued at approximately $1,269,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on KVUE. Barclays lifted their target price on shares of Kenvue from $21.00 to $23.00 and gave the company an "equal weight" rating in a report on Thursday. Citigroup decreased their target price on shares of Kenvue from $25.00 to $21.00 and set a "neutral" rating for the company in a research note on Wednesday, January 15th. Deutsche Bank Aktiengesellschaft cut Kenvue from a "buy" rating to a "hold" rating and dropped their price target for the company from $25.00 to $24.00 in a research report on Thursday, December 12th. Evercore ISI started coverage on Kenvue in a research report on Monday. They set an "in-line" rating and a $25.00 price objective for the company. Finally, Piper Sandler boosted their target price on Kenvue from $24.00 to $27.00 and gave the company an "overweight" rating in a report on Monday, February 24th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $24.00.

Remove Ads

Kenvue Price Performance

Shares of NYSE KVUE traded up $0.24 during trading on Friday, hitting $23.74. 14,401,327 shares of the company were exchanged, compared to its average volume of 16,745,932. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. Kenvue Inc. has a 1 year low of $17.67 and a 1 year high of $24.46. The company has a market cap of $45.36 billion, a price-to-earnings ratio of 44.78, a PEG ratio of 2.62 and a beta of 1.25. The firm's fifty day moving average price is $22.32 and its 200 day moving average price is $22.46.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The company reported $0.26 EPS for the quarter, hitting analysts' consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. On average, sell-side analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th were paid a $0.205 dividend. This represents a $0.82 annualized dividend and a yield of 3.45%. The ex-dividend date of this dividend was Wednesday, February 12th. Kenvue's payout ratio is currently 154.72%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.